Halaman 2 - Meduloblastoma Dokter Terbaik - TOP-68 dokter

Profesor Zvi Ram adalah ahli bedah saraf ternama di dunia yang memimpin European Association of Neurosurgical Societies. Beliau adalah pakar dalam bedah tumor otak yang kompleks dan pengembangan terapi berbasis gen yang inovatif untuk kanker otak.

• Spesialisasi dalam bedah saraf untuk tumor otak dan teknik invasif minimal
• Menjadi pakar dalam prosedur tingkat lanjut seperti pemetaan otak dan stimulasi otak dalam
• Terlatih secara internasional dalam bedah saraf dengan panduan gambar dan teknik mikrosurgis
• Penerima Penghargaan Goldhirsh Foundation untuk pengobatan neurologi yang inovatif
• Mengobati pasien di Sourasky Medical Center (Ichilov) di Israel

Dr. Yildiz telah banyak menerbitkan publikasi mengenai tumor neuroendokrin dan kanker langka, dengan penelitian yang dimuat dalam jurnal medis internasional.

• Spesialisasi dalam tumor neuroendokrin dan kasus kanker langka
• Menerbitkan 17+ artikel penelaahan sejawat di bidang onkologi
• Bekerja di Rumah Sakit Universitas Medipol Mega
• Berpengalaman dalam mendiagnosis dan menangani kasus onkologi yang kompleks

Professor Shlomi Constantini adalah pakar bedah saraf pediatrik, spesialis dalam tumor otak dan tulang belakang di Sourasky Medical Center.

• Pengalaman lebih dari 15 tahun di bidang bedah saraf
• Terlatih dalam bedah saraf mikro dan neuro-endoskopi tingkat lanjut
• Penerima Penghargaan Riset Klinis Terbaik Mahaly dari AANS
• Spesialisasi dalam intervensi bedah mikro dan rekonstruksi
• Anggota dari berbagai masyarakat bedah saraf internasional

Dr. Dror Levin berspesialisasi dalam kanker pediatrik, mengoordinasikan perawatan sarkoma di Sourasky Medical Center – fasilitas terkemuka di Israel.

• Direktur hematologi onkologi pediatrik di Sourasky
• Terdidik di Rizzoli Orthopaedic Institute – pemimpin global dalam kanker tulang
• Anggota ISPHO (Masyarakat Hematologi Onkologi Pediatrik Israel)
• Berspesialisasi dalam kelainan darah dan masalah pembekuan darah pada anak-anak

Univ. Prof. Dr. Wolfgang Köstler adalah ahli terkemuka dalam terapi kanker tertarget, dengan pengalaman lebih dari dua dekade di bidang onkologi medis.

• Spesialisasi dalam kanker payudara dan keganasan ginekologi
• Associate Professor di Universitas Kedokteran Wina
• Wakil Kepala Divisi Klinis Onkologi
• Fokus pada terapi kanker sistemik individual dan imunoterapi

Profesor Keil berspesialisasi dalam teknik pencitraan canggih untuk kasus-kasus kompleks, termasuk Medulloblastoma, di Rumah Sakit Akademik Solingen.

• Lulus dengan pujian dari Universitas Julius-Maximilian Würzburg
• Menjadi ahli dalam MRI, CT, dan ultrasonografi untuk diagnostik yang presisi
• Menjabat sebagai Kepala Dokter Radiologi Diagnostik dan Intervensi sejak 2022
• Menjalani pelatihan di bawah Profesor ternama Rolf W. Günther di Aachen

Prof. Deniz Konya berspesialisasi dalam tumor tulang belakang di Rumah Sakit Medical Park Göztepe, dengan pengalaman bedah saraf selama lebih dari 15 tahun.

• Menjalani pelatihan di Brigham and Women's Hospital, Harvard Medical School
• Anggota dewan Turkish Spine Society dan kelompok tulang belakang internasional
• Menerbitkan 47 makalah tinjauan sejawat tentang perawatan tulang belakang
• Melakukan prosedur tingkat lanjut untuk patah tulang dan deformitas tulang belakang

Assoc. Prof. Nail Paksoy menghadirkan keahlian khusus dalam medulloblastoma dari fellowship-nya di Institut Onkologi Universitas Istanbul dan perannya saat ini di Rumah Sakit Medipol Bahçelievler.

• Sertifikasi ESMO dalam Onkologi Medis
• Berpartisipasi dalam 8 uji klinis internasional untuk kanker stadium lanjut
• Mempublikasikan berbagai studi peer-review tentang pengobatan kanker langka
• Menyelesaikan pelatihan fellowship ganda dalam Onkologi Medis serta Alergi-Imunologi

Dr. Inta Jaunalksne berspesialisasi dalam viroterapi – sebuah pendekatan mutakhir dalam imunologi dengan pengalaman lebih dari 30 tahun.

• Kepala Pusat Imunologi Klinis di Rumah Sakit Universitas Klinis Pauls Stradins
• Lulusan Institut Medis Riga dengan magang di Penyakit Dalam
• Berfokus pada perawatan imunologi yang inovatif

Spesialis dalam Medulloblastoma dengan pelatihan ekstensif dalam onkologi medis di Universitas Akdeniz.

• Tersertifikasi dewan dalam onkologi medis sejak 2018
• Lebih dari 15 tahun pengalaman di bidang onkologi
• Bekerja di Kompleks Rumah Sakit Medical Park Antalya

Dr. Irfan Cicin is a Professor of Medical Oncology at the Trakya University Faculty of Medicine (2015–present). He has over 20 years of medical oncology experience and has held academic roles since 2010.

Education: MD, Istanbul University – Cerrahpaşa (1991–1997). Residency in Internal Medicine, Trakya University (1997–2002). Fellowship in Medical Oncology, Trakya University (2002–2004).

Practice: Medical Oncologist, Trakya University (2005–2008). Medical Oncologist, Elazığ Training and Research Hospital (2008–2010). Associate Professor of Medical Oncology, Trakya University (2010–2015). He previously served as a physician in the Turkish Air Force at Etimesgut Military Hospital (2004–2005).

Assoc. Prof. Atakan Topçu, M.D., is a medical oncologist at Medipol University and Medipol Acıbadem Regional Hospital. He treats solid tumors, including lung, breast, colorectal, gastric, and neuroendocrine cancers. His work also covers targeted therapies, immunotherapy, geriatric oncology, and cancer-related malnutrition, cachexia, and sarcopenia.

He has authored more than 50 peer-reviewed papers. Recent work includes a 2024 Frontiers in Medicine study on geriatric syndromes and a 2023 Future Oncology paper on sarcopenia and anxiety in lung cancer. He has also published on the CONUT score in breast cancer and on malnutrition in HER2-negative metastatic gastric cancer.

Dr. Topçu serves on the Editorial Board of BMC Cancer. He is a member of the Turkish Society of Medical Oncology, ESMO, and the Turkish Geriatrics Society. Education and training: M.D., Uludağ University; residency in Internal Medicine, Marmara University; fellowship in Medical Oncology, Bezmialem Vakıf University.

Dr. Yuri Goldes is a general surgeon with more than 20 years of clinical experience. He specializes in upper gastrointestinal and oncologic surgery. He is Deputy Director of the Department of General Surgery and Transplantation at Sheba Medical Center in Tel Aviv. He also leads the Upper GI Surgery Unit. He was named to Forbes Israel’s Best Doctors in 2025. He is ranked among Israel’s Best Gastrointestinal Surgeons by Forbes. In 2019, he received the Israeli Ministry of Health “Best Doctor of the Year” award.

He is an expert in advanced minimally invasive and robotic surgery. He treats diaphragmatic hernia, achalasia, GERD, and gallbladder disease. He also performs oncologic surgery for pancreatic, gastric, and esophageal cancers. He uses laparoscopic and robotic techniques.

He pioneered some of Israel’s first robotic oncologic resections of the stomach and pancreas. He is among a small group worldwide who perform minimally invasive Whipple procedures (pancreaticoduodenectomy) using advanced laparoscopy. He applies methods that improve outcomes and speed recovery. He provides personalized care.

Dr. Muhammed Mustafa Atci is an Associate Professor of Medical Oncology at İstinye University, Liv Hospital Topkapı (2025–present). He previously served as Associate Professor and Education Coordinator at Prof. Dr. Cemil Taşcıoğlu City Hospital (2023–2025). He was also a Medical Oncologist there (2018–2021).

He has been a member of ASCO and the Turkish Society of Medical Oncology since 2018. He is the author or co-author of 19 peer-reviewed international papers on colon, breast, gastric, pancreatic, lung, thyroid, sarcoma, and colorectal cancers.

Notable works include a multicentre study on stage IIB colon cancer survival (Journal of Chemotherapy). He also studied the De Ritis ratio for lung metastasis in testicular cancer (Current Urology). His prognostic studies used PET/CT, MSI, lymph node ratio, and metabolic tumor volume.

Assoc. Prof. Ayşe İrem Yasin, M.D., is a medical oncologist who specializes in solid tumors. Her clinical focus includes breast, lung, gastrointestinal, gynecologic, and urologic cancers. She also treats brain and other CNS tumors, soft tissue sarcomas, head and neck cancers, adenocarcinomas, melanoma, Merkel cell carcinoma, and cancers of unknown primary. She practices at Medipol Acıbadem District Hospital (2025–present). She previously worked at Şişli Etfal Training and Research Hospital (2023–2025).

She completed a Medical Oncology fellowship at Bezmialem Vakıf University (2019–2022). This followed an Internal Medicine residency at the same institution (2012–2016). Her international experience includes the Breast Cancer Unit at the University of Piemonte Orientale in Novara (2022). She also trained at Basel University Hospital, Cleveland Clinic, and Harvard Medical School. She holds the ESMO Board Certificate (2022).

Dr. Maha Yahia is a medical oncologist and hemato-oncologist. She provides assessment, diagnosis, and treatment planning. Her treatments include chemotherapy, targeted therapy, and immunotherapy. She cares for patients with breast, genitourinary, gynecologic, thoracic, gastrointestinal, and rare cancers.

Education: M.B.B.Ch, Kasr El-Aini, Cairo University (1997–2003). Master in Hemato-oncology, National Cancer Institute, Cairo University (2008). Doctoral Degree in Hemato-oncology, National Cancer Institute, Cairo University (2015).

Experience: Resident in Medical Oncology, Maadi AFMC (2005–2010). Visitor Resident, NCI Cairo (2008–2009). Consultant Assistant, Prof. Hussein Khaled Clinic (2010–2017). Specialist, International Medical Center (2011–2012), Wadi El Nile Hospital (2013–2014), and Maadi AFMC (2011–2018). Head, Clinical Research Support Team, Maadi AFMC (2016–2018). Major (2014–2016) and Lt. Colonel Doctor (2016–2018), Egyptian Armed Forces. Lecturer of Clinical Research, AFCM (2019–2021).

Dr. Mariam Mohammed Hussein Abu Zeid is a clinical oncologist. She treats solid tumors and hematologic cancers. She earned her MBBCh from Ain Shams University in 2007 (Excellent). She completed a Master’s in Clinical Oncology and Nuclear Medicine in 2011 (Very Good). She received a Ph.D. in 2018 and an ESMO Certificate in 2015.

She leads and monitors clinical trials. Her work includes data collection and analysis. She administers chemotherapy and manages treatment toxicities. She also plans care with multidisciplinary teams. Her experience includes Ain Shams University Hospitals (2009–2012), the International Medical Center (2012–2014), and Wadi El Nile Hospital (2015–2019). Her roles covered diagnosis and staging, supportive care, quality improvement, and screening. She educates patients and families about the diagnosis, treatment options, and palliative care.

Dr. Mohamed Mahmoud Abdelhakim is Head of Radiation Oncology at Shefa al Orman Hospital, Luxor. He is Professor of Radiation Oncology at the National Cancer Institute, Cairo University. He previously served as Associate Professor (2015–2020), Lecturer (2010–2015), Assistant Lecturer (2003–2009), and Resident (2000–2003). He also worked as a Specialist at Gharbia Cancer Society.

He treats inpatients and outpatients with breast, soft tissue sarcoma, lymphoma, gynecologic, gastrointestinal, genitourinary, and CNS tumors. His skills include image-guided brachytherapy, IMRT, VMAT, SRS, and SBRT. He performs conventional and CT-based planning and 3D-CRT. He works with cobalt and linear accelerators and electron beam therapy. He provides HDR and LDR intracavitary and interstitial brachytherapy. He also performs stereotactic radiotherapy, total body irradiation, and total skin irradiation.

Member: Egyptian Cancer Society, ESTRO, ESMO.

Professor Raanan Berger, MD PhD, is a medical oncologist and radiotherapist. He is Director of the Cancer Center at Sheba Medical Center and heads its clinical research unit. He was listed in Forbes Israel’s “Best Doctors” (2025). He leads the genitourinary oncology program with a focus on prostate cancer. His care includes systemic therapy and radiotherapy in a multidisciplinary, patient-centered model.

He is board-certified in oncology. He earned his MD and PhD at Tel Aviv University and completed his clinical training at Sheba. He then completed a postdoctoral fellowship at Dana-Farber/Harvard, focusing on prostate cancer with Dr. Philip Kantoff and molecular oncology in Dr. William C. Hahn’s lab. He is a member of ESMO and ASCO. He has co-authored more than 20 peer-reviewed papers, including studies on outcomes in high- versus very high-risk prostate cancer and on BRCA1/2 in large cohorts.